CME for Reviewers
The American Association of Blood Banks (AABB) with Wiley now offers continuing medical education (CME) credit for peer review of manuscripts submitted to the journal. Peer reviewers may request 3.0 AMA PRA Category 1 Credits™ per original manuscript being reviewed. Reviewers may only claim CME credit once per manuscript. Credit claims for additional rounds of review will not be awarded.
To submit a request for CME credit, the manuscript reviewer must complete the required CME questions within their review submission form online. Following submission, your request for credit will then be processed. Please note that requests for CME credit are only possible during initial submission of your review.
Certificates for all approved requests will be issued out by email on a monthly basis. A copy of your certificate will be held on file by the accredited provider for later access. If you require a replacement copy of your certificates, or if you have any questions regarding the program, please contact the accredited provider at [email protected].
Click here to learn more about the peer review process.
Educational Objective
Upon the completion of this activity, the participant will be better able to evaluate literature within the field of hematology, blood banking, and transfusion medicine.
Activity Disclosures
No commercial support has been accepted related to the development or publication of this activity.
Faculty and Disclosures
Editor-in-Chief
Paul M. Ness, MD discloses the following relevant financial relationships: providing Medical Advising for TeramoBCT and a member of the Scientific Advising Board for New Health Sciences.
Associate Editors
Michael P. Busch, MD, PhD discloses the following relevant financial relationships: funded research from Grifols and Terumo, and his role on the Scientific Advisory Committee for Quotient.
Jose A. Cancelas, MD, PhD discloses the following relevant financial relationships: contract for research for Cerus Co., Ferurrano BCT, Citra Labs and his role on the Advisory Committee for New Health Sciences.
Larry J. Dumont, PhD discloses the following relevant financial relationships: sponsored research for CitraLab/BioMet, Cerus Corp., and EryDel, S.p.A, Scientific Member, Treasurer, Past Chair for BEST Collaborative, Consultant and Scientific Advisory Board for New Health Sciences and Cellphire, Inc., and Consutant for HemaCue and CitraLab/BioMet.
Willy Flegel, MD discloses the following relevant financial relationships: royalties for RHD patents from DRK Blutspendedienst Ba-Wu-He Inventor/owner.
Cassandra D. Josephson, MD discloses the following relevant financial relationships: consultant for Immucor and Biomet Zimmer.
Jay E. Menitove, MD discloses the following relevant financial relationships: ownership of common stock for Amgen/Jay Menitove, public member/Chair of the HHS Advisory Committee on Blood and Tissue Safety and Availability, and part-time employment for CSL Plasma.
Edward L. Snyder, MD, FACP, discloses the following relevant financial relationships: Clinical Trials for Cerus and DSMB Octaplas.
Johnathan H. Waters, MD discloses grant support and honorarium from Haemonetics.
Anne F. Eder, MD, PhD, Nancy M. Heddle, MSc, FCSMLS(D), Beth Shaz, MD, Connie Westhoff, PhD, Ronald G. Strauss, MD, Richard M. Kaufman, MD, and Karen E. King, MD reported no conflicts of interest or relevant financial relationships.
Conflicts of interest have been identified and resolved in accordance with John Wiley and Sons, Inc.’s Policy on Activity Disclosure and Conflict of Interest.
Accreditation
John Wiley and Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
John Wiley and Sons, Inc. designates this manuscript review activity for a maximum of 3.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.